609 related articles for article (PubMed ID: 10800633)
1. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
[TBL] [Abstract][Full Text] [Related]
2. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects.
Kreutner W; Hey JA; Chiu P; Barnett A
Arzneimittelforschung; 2000 May; 50(5):441-8. PubMed ID: 10858871
[TBL] [Abstract][Full Text] [Related]
3. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
[TBL] [Abstract][Full Text] [Related]
4. Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
Llupià J; Gras J; Llenas J
Arzneimittelforschung; 2003; 53(2):93-7. PubMed ID: 12642964
[TBL] [Abstract][Full Text] [Related]
5. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
7. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
[TBL] [Abstract][Full Text] [Related]
8. Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor.
Kakiuchi M; Ohashi T; Musoh K; Kawamura K; Morikawa K; Kato H
Jpn J Pharmacol; 1997 Apr; 73(4):291-8. PubMed ID: 9165365
[TBL] [Abstract][Full Text] [Related]
9. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
[TBL] [Abstract][Full Text] [Related]
10. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
[TBL] [Abstract][Full Text] [Related]
11. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
Yanni JM; Stephens DJ; Miller ST; Weimer LK; Graff G; Parnell D; Lang LS; Spellman JM; Brady MT; Gamache DA
J Ocul Pharmacol Ther; 1996; 12(4):389-400. PubMed ID: 8951675
[TBL] [Abstract][Full Text] [Related]
12. Effect of loratadine on immediate and delayed type hypersensitivity reactions.
Tasaka K; Kamei C; Akagi M; Mio M; Izushi K; Yoshida T; Nakamura S
Arzneimittelforschung; 1995 Jul; 45(7):796-804. PubMed ID: 8573225
[TBL] [Abstract][Full Text] [Related]
13. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.
Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
Drugs R D; 2005; 6(6):371-84. PubMed ID: 16274260
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic effects of desloratadine, the major metabolite of loratadine, in rabbit and guinea-pig iris smooth muscle.
Cardelús I; Antón F; Beleta J; Palacios JM
Eur J Pharmacol; 1999 Jun; 374(2):249-54. PubMed ID: 10422766
[TBL] [Abstract][Full Text] [Related]
15. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
Poizot A; Dumez D; Ferrandon P; Lefournier C; Michel A; Armstrong JM
Arzneimittelforschung; 1986 Apr; 36(4):695-702. PubMed ID: 2424463
[TBL] [Abstract][Full Text] [Related]
16. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor.
Anthes JC; Gilchrest H; Richard C; Eckel S; Hesk D; West RE; Williams SM; Greenfeder S; Billah M; Kreutner W; Egan RE
Eur J Pharmacol; 2002 Aug; 449(3):229-37. PubMed ID: 12167464
[TBL] [Abstract][Full Text] [Related]
18. In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist.
Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
Drugs R D; 2006; 7(4):219-31. PubMed ID: 16784247
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological activity evaluation of desloratadine analogues as H1 receptor antagonists.
Lin Y; Wang Y; Sima LF; Wang DH; Cao XH; Chen LG; Chen B
Bioorg Med Chem; 2013 Jul; 21(14):4178-85. PubMed ID: 23719280
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin.
Denham KJ; Boutsiouki P; Clough GF; Church MK
Inflamm Res; 2003 Oct; 52(10):424-7. PubMed ID: 14520518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
